NKTR
Nektar Therapeutics
NASDAQ · USHealthcareBiotechnology
$64.84-5.01%
Price as of Jul 20, 2026
NKTR valuation
Nektar Therapeutics valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 47.65x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.80x
- Price / sales
- 39.38x
- Price / cash flow
- -10.75x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 31.74x
- EV / EBITDA
- -14.02x
- EV / EBIT
- -14.11x
- Market cap
- $2.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.